SAT-019 ACEi/ARBs, β-blockers or Both in incident End-Stage Renal Disease patients without Cardiovascular Disease: A Propensity-Matched longitudinal study in a Nationwide cohort

Kidney International Reports(2019)

引用 0|浏览22
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要